NCT01341990

Brief Summary

The purpose of the study is to evaluate the effect of an investigational multi-purpose disinfecting solution (MPDS) compared to a marketed multi-purpose solution on the moisture of silicone hydrogel contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 9, 2009

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2010

Completed
1.3 years until next milestone

First Posted

Study publicly available on registry

April 26, 2011

Completed
12 months until next milestone

Results Posted

Study results publicly available

April 13, 2012

Completed
Last Updated

April 13, 2012

Status Verified

March 1, 2012

Enrollment Period

2 months

First QC Date

December 9, 2009

Results QC Date

March 21, 2012

Last Update Submit

March 21, 2012

Conditions

Keywords

Contact LensesContact Lens CareMulti-Purpose Solution

Outcome Measures

Primary Outcomes (2)

  • Mean Ex-Vivo Advancing Contact Angle

    Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.

    Day 1, 8 hours

  • Mean Ex-Vivo Advancing Contact Angle

    Study lens was removed from the eye according to protocol-specified procedures. The OCA15 (Optical Contact Angle) Instrument was used to observe, record, and calculate contact angle measurements. The wetting angle measurement was recorded in degrees (0-180), and a lower wetting angle measurement indicates a more wettable lens.

    Day 8, 16 hours

Study Arms (2)

FID 114675A

EXPERIMENTAL

Multi-purpose disinfecting solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses

Device: FID 114675A Multi-Purpose Disinfecting Solution (MPDS)Device: Silicone Hydrogel Contact Lenses

ReNu MultiPlus

ACTIVE COMPARATOR

Multi-purpose solution used per protocol-specified instructions for cleaning, rinsing, disinfecting/storing, and reinserting study contact lenses

Device: ReNu Fresh Lens Comfort Multi-Purpose Solution (MPS)Device: Silicone Hydrogel Contact Lenses

Interventions

Investigational solution intended for use as a cleaning, rinsing, reconditioning, disinfecting, and storage solution for silicone hydrogel and soft contact lenses

FID 114675A

Commercially marketed prodouct indicated for cleaning, removing protein deposits, rinsing, disinfecting, and storing soft contact lenses

Also known as: ReNu MultiPlus® Multi-Purpose Solution Fresh Lens Comfort™
ReNu MultiPlus

Commercially marketed silicone hydrogel contact lenses per habitual prescription for daily wear use, at least 8 hours/day. New pair dispensed at Day 0 (Baseline Visit) and at the conclusion of Day 1 (Visit 2).

Also known as: Acuvue® Oasys™, PureVision®
FID 114675AReNu MultiPlus

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older.
  • Wears silicone hydrogel contact lenses on a daily wear basis i.e. disinfects lenses every night).
  • Has successfully worn contact lenses for 5 days, 8 hours per day, prior to baseline visit.
  • Vision is correctable to 20/30 or better in each eye at distance with study lenses at baseline visit.

You may not qualify if:

  • Known sensitivity or intolerance to contact lens multi-purpose solutions.
  • Use of any topical ocular OTC or prescribed topical ocular medications.
  • History or current ocular infections or ocular inflammatory events.
  • Ocular surgery within the past year.
  • Medical condition or use of medication that cause ocular side effects.
  • Participation in any investigational study within the past 30 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Contact Alcon Call Center for Trial Locations

Fort Worth, Texas, 76134, United States

Location

Results Point of Contact

Title
Director of Alcon Clinical
Organization
Alcon Research, Ltd.

Study Officials

  • Justin R Webb, OD

    Alcon Research

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2009

First Posted

April 26, 2011

Study Start

November 1, 2009

Primary Completion

January 1, 2010

Study Completion

January 1, 2010

Last Updated

April 13, 2012

Results First Posted

April 13, 2012

Record last verified: 2012-03

Locations